Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,36 USD | -10,11% | -14,40% | +19,77% |
12/04 | Sectorupdate: Aandelen in de gezondheidszorg stabiel voor de beurs op vrijdag | MT |
12/04 | Sectorupdate: Gezondheidszorg | MT |
Vakgebied
Aantal werknemers: 284
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Small Molecule and Cell Therapies
100,0
%
| 39 | 100,0 % | 77 | 100,0 % | +99,31% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 39 | 100,0 % | 77 | 100,0 % | +99,31% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Arthur Sands
CEO | Chief Executive Officer | 62 | 18-09-14 |
Hans van Houte
DFI | Director of Finance/CFO | 58 | 01-01-15 |
Chief Tech/Sci/R&D Officer | - | 01-09-21 | |
Paula O’Connor
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-22 |
Gwenn Hansen
CTO | Chief Tech/Sci/R&D Officer | 53 | 01-01-15 |
Christine Ring
CMP | Compliance Officer | 59 | 01-09-19 |
Silinda Neou
IRC | Investor Relations Contact | - | 01-08-22 |
Public Communications Contact | - | 13-07-20 | |
Raf Lambrecht
LAW | General Counsel | - | 01-04-20 |
Michael T. Lotze
PRN | Corporate Officer/Principal | - | 01-06-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Judith Reinsdorf
BRD | Director/Board Member | 60 | 01-10-21 |
Paul Silva
BRD | Director/Board Member | 58 | 01-10-21 |
Arthur Sands
CEO | Chief Executive Officer | 62 | 18-09-14 |
Julia Gregory
BRD | Director/Board Member | 71 | 01-08-19 |
Lori Kunkel
BRD | Director/Board Member | 66 | 01-07-19 |
David Lacey
CHM | Chairman | 71 | 01-04-16 |
Edward Saltzman
BRD | Director/Board Member | 69 | 12-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 59 303 621 | 58 000 976 ( 97,80 %) | 0 | 97,80 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,77% | 733 mln. | |
-2,26% | 103 mld. | |
+1,41% | 95,71 mld. | |
+0,79% | 22,02 mld. | |
-17,84% | 20,9 mld. | |
-11,11% | 17,85 mld. | |
-42,83% | 16,21 mld. | |
-17,63% | 15,52 mld. | |
+4,55% | 13,86 mld. | |
+32,11% | 12,04 mld. |
- Beurs
- Aandelen
- Koers NRIX
- Onderneming Nurix Therapeutics, Inc.